RESUMO
The activity of glycogen phosphorylase, an enzyme that is activated by both cAMP and calcium, was used as an indicator of the state of the cytoplasm after chemotactic stimulation of polymorphonuclear leukocytes (neutrophils). The activity of the enzyme showed a clear dependence on cytoplasmic calcium. Addition of the calcium ionophore A23187 caused a 4-5-fold increase in activity of phosphorylase a. In the absence of external Ca2+, A23187 caused only brief transient activation of phosphorylase; probably reflecting release of sequestered intracellular Ca2+. Addition of the chemotactic peptide N-formylnorleucylleucylphenylalanine (FNLLP) caused a transient 2-3-fold activation of the enzyme. The dose-dependence of activation by FNLLP showed a peak at 10(-8) M, near the Kd of the receptor for FNLLP. The phosphorylase activity peaks by 90 s and then declines, returning to basal levels by 20 min after stimulation with 10(-8) M peptide and by 60 min with 10(-7) M peptide. This finding suggests that the cells do not need to maintain elevated cytoplasmic calcium levels to exhibit stimulated locomotion. Thus, if calcium continues to modulate the motility, there either must be highly localized changes that are not detected in measures of the total cytoplasm, or the sensitivity to calcium must be variable such that basal levels are sufficient to maintain locomotion. Cells loaded with the fluorescence calcium probe quin2 (0.6 mM) in the presence or absence of external Ca2+ had elevated phosphorylase levels before addition of FNLLP. Thus, the presence of quin2 may alter the cytoplasmic Ca2+ level, and it clearly alters some aspects of the neutrophil physiology. Phosphorylase a appears to be a sensitive, nonperturbing indicator of the cytoplasmic calcium levels.
Assuntos
Cálcio/farmacologia , Fatores Quimiotáticos/farmacologia , Neutrófilos/enzimologia , Fosforilase a/metabolismo , Fosforilases/metabolismo , 8-Bromo Monofosfato de Adenosina Cíclica/farmacologia , Aminoquinolinas/farmacologia , Bucladesina/farmacologia , Calcimicina/farmacologia , Quimiotaxia de Leucócito/efeitos dos fármacos , Relação Dose-Resposta a Droga , Ativação Enzimática/efeitos dos fármacos , Neutrófilos/efeitos dos fármacos , Oligopeptídeos/antagonistas & inibidores , Oligopeptídeos/farmacologia , Fosforilase b/metabolismo , Fatores de Virulência de Bordetella/farmacologiaRESUMO
Adenosine monophosphate is required for the activation of glycogen phosphorylase b and for release of the inhibition of phosphorylase a by glucose. Two molecules of adenosine monophosphate (AMP) bind to symmetry related sites at the subunit interface of the phosphorylase dimer. Adenosine triphosphate (ATP) binds to the same site, but does not promote catalytic activity. The structure of glucose-inhibited phosphorylase a bound to AMP and also of the complex formed with glucose and ATP is described. Crystallographic refinement of these complexes reveals that structural changes are associated with AMP but not ATP binding. The origin of these effects can be traced to different effector binding modes exhibited by AMP and ATP, respectively. The conformational changes associated with AMP binding traverse multiple paths in the enzyme and link the effector and catalytic sites.
Assuntos
Fosforilase a/metabolismo , Fosforilases/metabolismo , Monofosfato de Adenosina/metabolismo , Trifosfato de Adenosina/metabolismo , Sítios de Ligação , Ativação Enzimática , Conformação ProteicaRESUMO
The crystal structure of glycogen phosphorylase a complexed with its substrates, orthophosphate and maltopentaose, has been determined and refined at a resolution of 2.8 angstroms. With oligosaccaride bound at the glycogen storage site, the phosphate ion binds at the catalytic site and causes the regulatory and catalytic domains to separate with the loss of stabilizing interactions between them. Homotropic cooperativity between the active sites of the allosteric dimer results from rearrangements in isologous contacts between symmetry-related helices in the subunit interface. The conformational changes in the core of the interface are correlated with those observed on covalent activation by phosphorylation at Ser14 (phosphorylase b----a).
Assuntos
Fosforilase a/metabolismo , Fosforilases/metabolismo , Sítio Alostérico , Sequência de Aminoácidos , Sítios de Ligação , Catálise , Cristalização , Cristalografia , Ativação Enzimática , Glucofosfatos/metabolismo , Glicogênio/metabolismo , Substâncias Macromoleculares , Dados de Sequência Molecular , Estrutura Molecular , Oligossacarídeos , Fosfatos/metabolismo , Conformação Proteica , Difração de Raios XRESUMO
Protein dephosphorylation by phosphatase PP1 plays a central role in mediating the effects of insulin on glucose and lipid metabolism. A PP1C-targeting protein expressed in 3T3-L1 adipocytes (called PTG, for protein targeting to glycogen) was cloned and characterized. PTG was expressed predominantly in insulin-sensitive tissues. In addition to binding and localizing PP1C to glycogen, PTG formed complexes with phosphorylase kinase, phosphorylase a, and glycogen synthase, the primary enzymes involved in the hormonal regulation of glycogen metabolism. Overexpression of PTG markedly increased basal and insulin-stimulated glycogen synthesis in Chinese hamster ovary cells overexpressing the insulin receptor, which do not express endogenous PTG. These results suggest that PTG is critical for glycogen metabolism, possibly functioning as a molecular scaffold.
Assuntos
Proteínas de Transporte/metabolismo , Glicogênio/metabolismo , Peptídeos e Proteínas de Sinalização Intracelular , Fosfoproteínas Fosfatases/metabolismo , Células 3T3 , Sequência de Aminoácidos , Animais , Células CHO , Proteínas de Transporte/química , Proteínas de Transporte/genética , Clonagem Molecular , Cricetinae , DNA Complementar/genética , Glicogênio/biossíntese , Glicogênio Sintase/metabolismo , Insulina/farmacologia , Camundongos , Dados de Sequência Molecular , Fosforilase Quinase/metabolismo , Fosforilase a/metabolismo , Fosforilação , Ligação Proteica , Proteína Fosfatase 1 , Proteínas Recombinantes de Fusão/metabolismo , Especificidade por Substrato , TransfecçãoRESUMO
OBJECTIVE: To determine insulin sensitivity, proportions of muscle fiber types, and activities of glycogenolytic and glycolytic enzymes in Belgians with and without polysaccharide storage myopathy (PSSM). ANIMALS: 10 Quarter Horses (QHs) and 103 Belgians in which PSSM status had been determined. PROCEDURES: To determine insulin sensitivity, a hyperinsulinemic euglycemic clamp (HEC) technique was used in 5 Belgians with PSSM and 5 Belgians without PSSM. Insulin was infused i.v. at 3 mU/min/kg for 3 hours, and concentrations of blood glucose and plasma insulin were determined throughout. An i.v. infusion of glucose was administered to maintain blood glucose concentration at 100 mg/dL. Activities of glycogenolytic and glycolytic enzymes were assessed in snap-frozen biopsy specimens of gluteus medius muscle obtained from 4 Belgians with PSSM and 5 Belgians without PSSM. Percentages of type 1, 2a, and 2b muscle fibers were determined via evaluation of >or= 250 muscle fibers in biopsy specimens obtained from each Belgian used in the aforementioned studies and from 10 QHs (5 with PSSM and 5 without PSSM). RESULTS: Belgians with and without PSSM were not significantly different with respect to whole-body insulin sensitivity, muscle activities of glycogenolytic and glycolytic enzymes, or proportions of muscle fiber types. However, Belgians had an increased proportion of type 2a and decreased proportion of type 2b muscle fibers, compared with proportions in QHs, regardless of PSSM status. CONCLUSIONS AND CLINICAL RELEVANCE: PSSM in Belgians may be attributable to excessive glycogen synthesis rather than decreased glycogen utilization or enhanced glucose uptake into muscle cells.
Assuntos
Doença de Depósito de Glicogênio/veterinária , Doenças dos Cavalos/sangue , Resistência à Insulina/fisiologia , Doenças Musculoesqueléticas/veterinária , Animais , Biópsia/veterinária , Glicemia/metabolismo , Feminino , Técnica Clamp de Glucose/veterinária , Doença de Depósito de Glicogênio/sangue , Doença de Depósito de Glicogênio/enzimologia , Histocitoquímica/veterinária , Cavalos , Insulina/sangue , L-Lactato Desidrogenase/metabolismo , Masculino , Fibras Musculares Esqueléticas/metabolismo , Músculo Esquelético/enzimologia , Músculo Esquelético/metabolismo , Doenças Musculoesqueléticas/sangue , Doenças Musculoesqueléticas/enzimologia , Fosfofrutoquinase-1 Muscular/metabolismo , Fosfoglucomutase/metabolismo , Fosfoglicerato Mutase/metabolismo , Fosforilase a/metabolismoRESUMO
Activation of either coexisting beta1- or beta2 -adrenoceptors with noradrenaline or adrenaline, respectively, causes maximum increases of contractility of human atrial myocardium. Previous biochemical work with the beta2 -selective agonist zinterol is consistent with activation of the cascade beta2 -adrenoceptors-->Gsalpha-protein-->adenylyl cyclase-->cAMP-->protein kinase (PKA)-->phosphorylation of phospholamban, troponin I, and C-protein-->hastened relaxation of human atria from nonfailing hearts. However, in feline and rodent myocardium, catecholamines and zinterol usually do not hasten relaxation through activation of beta2 -adrenoceptors, presumably because of coupling of the receptors to Gi protein. It is unknown whether the endogenously occurring beta2 -adrenoceptor agonist adrenaline acts through the above cascade in human atrium and whether its mode of action could be changed in heart failure. We assessed the effects of (-)-adrenaline, mediated through beta2 -adrenoceptors (in the presence of CGP 20712A 300 nM to block beta1 -adrenoceptors), on contractility and relaxation of right atrial trabecula obtained from nonfailing and failing human hearts. Cyclic AMP levels were measured as well as phosphorylation of phospholamban, troponin I, and protein C with Western blots and the back-phosphorylation procedure. For comparison, beta1 -adrenoceptor-mediated effects of (-)-noradrenaline were investigated in the presence of ICI 118,551 (50 nM to block beta2 -adrenoceptors). The positive inotropic effects of both (-)-noradrenaline and (-)-adrenaline were accompanied by reductions in time to peak force and time to reach 50% relaxation. (-)-Adrenaline caused similar positive inotropic and lusitropic effects in atrial trabeculae from failing hearts. However, the inotropic potency, but not the lusitropic potency, of (-)-noradrenaline was reduced fourfold in atrial trabeculae from heart failure patients. Both (-)-adrenaline and (-)-noradrenaline enhanced cyclic AMP levels and produced phosphorylation of phospholamban, troponin I, and C-protein to a similar extent in atrial trabeculae from nonfailing hearts. The hastening of relaxation caused by (-)-adrenaline together with the PKA-catalyzed phosphorylation of the three proteins involved in relaxation, indicate coupling of beta2 -adrenoceptors to Gs protein. The phosphorylation of phospholamban at serine16 and threonine17 evoked by (-)-adrenaline through beta2 -adrenoceptors and by (-)-noradrenaline through beta1 -adrenoceptors was not different in atria from nonfailing and failing hearts. Activation of beta2 -adrenoceptors caused an increase in phosphorylase a activity in atrium from failing hearts further emphasizing the presence of the beta2 -adrenoceptor-Gsalpha-protein pathway in human heart. The positive inotropic and lusitropic potencies of (-)-adrenaline were conserved across Arg16Gly- and Gln27Glu-beta2 -adrenoceptor polymorphisms in the right atrium from patients undergoing coronary artery bypass surgery, chronically treated with beta1 -selective blockers. The persistent relaxant and biochemical effects of (-)-adrenaline through beta2 -adrenoceptors and of (-)-noradrenaline through beta1 -adrenoceptors in heart failure are inconsistent with an important role of coupling of beta2 -adrenoceptors with Gialpha-protein in human atrial myocardium.
Assuntos
Epinefrina/farmacologia , Subunidades alfa Gs de Proteínas de Ligação ao GTP/fisiologia , Insuficiência Cardíaca/fisiopatologia , Contração Miocárdica/fisiologia , Receptores Adrenérgicos beta 2/fisiologia , Agonistas Adrenérgicos/farmacologia , Antagonistas de Receptores Adrenérgicos beta 1 , Agonistas de Receptores Adrenérgicos beta 2 , Antagonistas Adrenérgicos beta/farmacologia , Adulto , Idoso , Apêndice Atrial/efeitos dos fármacos , Apêndice Atrial/fisiologia , Proteínas de Ligação ao Cálcio/metabolismo , Proteínas de Transporte/metabolismo , AMP Cíclico/metabolismo , Diástole/efeitos dos fármacos , Diástole/fisiologia , Epinefrina/química , Subunidades alfa Gi-Go de Proteínas de Ligação ao GTP/metabolismo , Subunidades alfa Gi-Go de Proteínas de Ligação ao GTP/fisiologia , Subunidades alfa Gs de Proteínas de Ligação ao GTP/metabolismo , Genótipo , Insuficiência Cardíaca/metabolismo , Humanos , Técnicas In Vitro , Isoproterenol/farmacologia , Masculino , Pessoa de Meia-Idade , Contração Miocárdica/efeitos dos fármacos , Norepinefrina/farmacologia , Fosforilase a/metabolismo , Fosforilação/efeitos dos fármacos , Receptores Adrenérgicos beta 2/genética , Troponina I/metabolismoRESUMO
The objective of the study was to evaluate the neuroprotective effects of bacoside A and bromelain against dichlorvos-incited toxicity. Healthy 6-8-week old, male Swiss mice were administered subacute doses of dichlorvos (40 mg/kg bw), bacoside A (5 mg/kg bw) and bromelain (70 mg/kg bw). AChE, BChE, GABA, serotonin and total protein content and their expressions were used for determination of toxic action of dichlorvos. Protective effects of bacoside A and bromelain were evaluated on the same parameters. Exposure to dichlorvos leads to significant decline in activities of AChE (p < 0.01, p < 0.001), BChE (p < 0.05) and GABA (p < 0.01) and total protein levels (p < 0.01). Antioxidant treatment significantly increased the activities of AChE (p < 0.01, p < 0.001), BChE (p < 0.05), GABA (p < 0.01) and total protein level (p < 0.05) compared to those in dichlorvos-treated mice. Overexpression of Hsp 70 protein and underexpression of phosphorylase a and b, catalase SOD and GPx were observed after dichlorvos exposure which suggests the oxidative stress. The results indicate that dichlorvos-induced neuronal damage which results in the generation of molecular expression of proteins is in agreement with the biochemical data ameliorated by bacoside A and bromelain.
Assuntos
Encéfalo/efeitos dos fármacos , Colinesterases/metabolismo , Diclorvós/toxicidade , Substâncias Protetoras/farmacologia , Serotonina/metabolismo , Ácido gama-Aminobutírico/metabolismo , Animais , Antioxidantes/farmacologia , Encéfalo/metabolismo , Bromelaínas/farmacologia , Catalase/metabolismo , Regulação para Baixo/efeitos dos fármacos , Proteínas de Choque Térmico HSP70/metabolismo , Masculino , Camundongos , Estresse Oxidativo/efeitos dos fármacos , Fosforilase a/metabolismo , Fosforilase b/metabolismo , Saponinas/farmacologia , Superóxido Dismutase/metabolismo , Triterpenos/farmacologia , Regulação para Cima/efeitos dos fármacosRESUMO
Glucokinase and phosphorylase both have a high control strength over hepatocyte glycogen metabolism and are potential therapeutic targets for type 2 diabetes. We tested whether combined phosphorylase inactivation and glucokinase activation is a more effective strategy for controlling hepatic glycogen metabolism than single-site targeting. Activation of glucokinase by enzyme overexpression combined with selective dephosphorylation of phosphorylase-a by an indole carboxamide that favors the T conformation of phosphorylase caused a greater stimulation of glycogen synthesis than the sum of either treatment alone. This result is explained by the complementary roles of elevated glucose-6-phosphate (G6P; a positive modulator) and depleted phosphorylase-a (a negative modulator) in activating glycogen synthase and also by synergistic inactivation of phosphorylase-a by glucokinase activation and the indole carboxamide. Inactivation of phosphorylase-a by the indole carboxamide was counteracted by 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside, which is metabolized to an AMP analog; this effect was reversed by G6P. Our findings provide further evidence for the inverse roles of G6P and AMP in regulating the activation state of hepatic phosphorylase. It is proposed that dual targeting of glucokinase and phosphorylase-a enables improved potency and efficacy in controlling hepatic glucose metabolism.
Assuntos
Amidas/farmacologia , Aminoimidazol Carboxamida/análogos & derivados , Glucoquinase/metabolismo , Hepatócitos/efeitos dos fármacos , Indóis/farmacologia , Glicogênio Hepático/metabolismo , Fosforilase a/antagonistas & inibidores , Monofosfato de Adenosina , Aminoimidazol Carboxamida/farmacologia , Animais , Interações Medicamentosas , Ativação Enzimática/efeitos dos fármacos , Expressão Gênica , Glicogênio Sintase/metabolismo , Hepatócitos/enzimologia , Técnicas In Vitro , Masculino , Fosforilase a/metabolismo , Ratos , Ratos Wistar , Ribonucleotídeos/farmacologiaRESUMO
We have previously reported on the M-phase specific dephosphorylation of pRb and identified a type 1 serine/threonine protein phosphatase (PP1) as the enzyme mediating pRb dephosphorylation. In this report, we have characterized the pRb-directed phosphatase activity found in mitotic cells with respect to dose dependence and demonstrate that the pRb isoform conversion detected in vitro mirrors the pRb isoform conversion which occurs during mitosis of intact cells. Cell fractionation and PP1 catalytic subunit isolation studies support the notion that the pRb-directed phosphatase activity involves subpopulations of PP1 catalytic subunits. Coprecipitation studies revealed that PP1 can form a complex with hypophosphorylated pRb which was converted from the hyperphosphorylated form in mitotic cell extracts. Taken together with data from previous reports in the literature, a model for the regulation of PP1 activity towards pRb during mitotic exit is proposed.
Assuntos
Mitose/fisiologia , Fosfoproteínas Fosfatases/metabolismo , Proteína do Retinoblastoma/metabolismo , Animais , Células Cultivadas , Fase G1 , Haplorrinos , Fosforilase a/metabolismo , FosforilaçãoRESUMO
Exposure of CV-1P cells to hypoxic conditions results in reversible cell cycle arrest concomitant with accumulation of pRB in the hypophosphorylated, growth suppressive form. Similar to cell cycle arrest induced by serum starvation, we show here that hypoxia-induced arrest is accompanied by a decrease in pRB-directed CDK4 and CDK2 activities, lower cyclin D and E protein levels, and by an increase in p27 protein abundance. Immunoprecipitation studies reveal an increase in p27 association with cyclin E-CDK2 complexes. In contrast to cell cycle arrest induced by serum starvation, hypoxia increases PP1-mediated pRB dephosphorylation. These data reveal that synergy between decreased pRB-directed cyclin/CDK activity and increased pRB-directed phosphatase activity contribute towards inducing and maintaining pRB in its hypophosphorylated, growth suppressive state during hypoxia.
Assuntos
Quinases relacionadas a CDC2 e CDC28 , Proteínas de Ciclo Celular , Hipóxia Celular/fisiologia , Quinases Ciclina-Dependentes/metabolismo , Proteínas Associadas aos Microtúbulos/metabolismo , Fosfoproteínas Fosfatases/metabolismo , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas Proto-Oncogênicas , Proteína do Retinoblastoma/metabolismo , Proteínas Supressoras de Tumor , Animais , Células Cultivadas , Ciclina E/metabolismo , Quinase 2 Dependente de Ciclina , Quinase 4 Dependente de Ciclina , Inibidor de Quinase Dependente de Ciclina p27 , Regulação para Baixo , Células Epiteliais , Fase G1/fisiologia , Haplorrinos , Fosforilase a/metabolismo , Fosforilação , Fase S/fisiologiaRESUMO
The ability of 8-azidoadenosine 5'-monophosphate (N3AMP) to act as a photoaffinity label for the AMP binding site on glycogen phosphorylase (EC 2.4.1.1) was tested. 8-Azidoadenosine 5'-monophosphate can replace AMP as an allosteric modifier of both phosphorylases a and b; the pH optimum and the extent of activation are comparable to that observed with AMP. 8-Azidoadenosine 5'-monophosphate resembles the natural activator in having a higher affinity for phosphorylase a. The effects of 8-azidoadenosine 5'-monophosphate and AMP on phosphorylase b are additive when each is present at a concentration which gives less than 50% activation. Increasing the concentration of the substrate, glucose 1-phosphate, decreases the apparent activation constant (Ka) for the interaction of 8-azidoadenosine 5'-monophosphate with phosphorylase b. Glucose 6-phosphate is an inhibitor of phosphorylase b with either AMP or 8-azidoadenosine 5'-monophosphate. In the presence of ultraviolet light, 8-azidoadenosine 5'-monophosphate is irreversibly incorporated into phosphorylase a; incorporation at the allosteric site can be reduced if AMP is added prior to irradiation. Under the conditions used in the photolysis experiments, 3--5% of the available AMP sites were labeled with 8-azidoadenosine 5'-monophosphate. The data indicate the potential usefulness of 8-azidoadenosine 5'-monophosphate as a probe for the AMP site on phosphorylase.
Assuntos
Monofosfato de Adenosina/análogos & derivados , Marcadores de Afinidade/metabolismo , Azidas , Fosforilases/metabolismo , Monofosfato de Adenosina/metabolismo , Regulação Alostérica , Animais , Ativação Enzimática , Luz , Músculos/enzimologia , Fosforilase a/metabolismo , Fosforilase b/metabolismo , Fosforilases/efeitos da radiação , CoelhosRESUMO
A protein phosphatase assay, selective for protein phosphatase 2A, has been developed. Bovine histone H1 phosphorylated by protein kinase C and [gamma-32P]ATP, designated H1(C), was tested as the substrate for various preparations of protein phosphatases 1 and 2A. The phosphatase 2A preparations were 10-60-times more active with H1(C) as the substrate when compared to phosphorylase a. The phosphatase 1 enzymes showed very little dephosphorylation of the H1(C) substrate, the activity being less than 5% of the phosphorylase phosphatase activity. This preference and selectivity was demonstrated for purified phosphatase preparations in addition to fresh tissue extracts. The assay provides a rapid, simple assay for the routine analysis of phosphatase 2A in the presence of phosphatase 1, without the use of heat-stable inhibitor proteins.
Assuntos
Histonas/metabolismo , Fosfoproteínas Fosfatases/metabolismo , Proteína Quinase C/metabolismo , Animais , Bovinos , Eletroforese em Gel de Poliacrilamida , Cinética , Fosforilase a/metabolismo , Proteína Fosfatase 1 , Proteína Fosfatase 2 , RatosRESUMO
We have demonstrated the interaction of 125I-labeled calmodulin with glycogen phosphorylase by four techniques: polyacrylamide gel overlay, sucrose density centrifugation, gel filtration chromatography, and affinity chromatography. Phosphorylase b has more affinity for calmodulin than does phosphorylase a. Under all conditions tested, the presence of calmodulin affects neither the enzymatic activity nor any kinetic characteristics of phosphorylase a or b. We present these results as evidence that while binding between calmodulin and phosphorylase clearly exists, it may not have a physiological role.
Assuntos
Proteínas de Ligação ao Cálcio/metabolismo , Calmodulina/metabolismo , Fosforilases/metabolismo , 3',5'-AMP Cíclico Fosfodiesterases/metabolismo , Animais , Encéfalo/enzimologia , Bovinos , Centrifugação com Gradiente de Concentração , Cromatografia de Afinidade , Eletroforese em Gel de Poliacrilamida , Fosforilase a/metabolismo , Fosforilase b/metabolismo , Ligação ProteicaRESUMO
We have purified and crystallized bovine liver phosphorylase a. Starting from 2.5 kg of liver, we obtain 250 mg of phosphorylase a, with a specific activity of 90 units/mg, representing 15% recovery. SDS polyacrylamide gels show three bands, a 95 kDa band with the same mobility as muscle phosphorylase, and two smaller bands of 55 kDa and 40 kDa, which are probably proteolytic fragments. These fragments remain associated and have native conformation and catalytic activity. Crystals which diffract to 2.8 A resolution, were prepared by the hanging drop method using polyethylene glycol PEG 4000 as precipitant. The crystals were prepared in the presence of activators maltotriose and phosphite and crack when placed in solutions containing the inhibitors glucose and caffeine. This suggests phosphorylase is present in an active conformation.
Assuntos
Fígado/enzimologia , Fosforilase a/isolamento & purificação , Fosforilases/isolamento & purificação , Compostos de Potássio , Animais , Bovinos , Cristalização , Eletroforese em Gel de Poliacrilamida , Peso Molecular , Fragmentos de Peptídeos/isolamento & purificação , Fosfatos , Fosforilase a/metabolismo , Polietilenoglicóis , Potássio , Conformação Proteica , TrissacarídeosRESUMO
Hepatic glycogen metabolism in aerobic and hypoxic conditions has been assessed with respect to glycogenolysis, phosphorylase alpha activity and nucleotide content. Insulin did not inhibit glycogen breakdown nor stimulate lipogenesis in the aerobic perfused liver. Partial ischaemia induced glycogen breakdown, release of glucose and changes in nucleotide content in the perfused liver. Phosphorylase alpha content increased within 2 min in response to total ischaemia, in vivo and in the perfused liver. This change was paralleled by an increase in hepatic AMP. Glycogen synthase alpha activity decreased, as did the hepatic content of both cyclic AMP and cyclic GMP.
Assuntos
Hipóxia/metabolismo , Glicogênio Hepático/fisiologia , Nucleotídeos de Adenina/metabolismo , Aerobiose/efeitos dos fármacos , Animais , Metabolismo dos Carboidratos , AMP Cíclico/metabolismo , GMP Cíclico/metabolismo , Glicogênio Sintase/metabolismo , Técnicas In Vitro , Isquemia/metabolismo , Masculino , Fosforilase a/metabolismo , RatosRESUMO
The three proteinases present in papaya latex: papain (EC 3.4.22.2) chymopapain and papaya proteinase III (EC 3.4.22.6), were standardized by active-site titration, and compared in proteolytic activity against azocasein, serum albumin and cartilage proteoglycan. The activities were all of the same order, although there were differences in pH dependence. SDS-polyacrylamide gel electrophoresis of the early products of digestion of albumin and phosphorylase a showed very similar patterns for the three papaya proteinases. Kinetic parameters for hydrolysis of benzyloxycarbonyl-phenylalanyl-arginyl-7(4-methyl)coumarylamide were determined for the three enzymes. Values for kcat/Km varied only within a factor of 2, but the individual constants were much higher for papain than for chymopapain and papaya proteinase III. In contrast to the results obtained with the synthetic substrate, the kinetic parameters for the initial hydrolysis of succinyl-albumin were very similar for the three papaya proteinases. This was consistent with their similar proteolytic activities in other assays.
Assuntos
Quimopapaína/metabolismo , Dipeptídeos , Endopeptidases/metabolismo , Papaína/metabolismo , Albumina Sérica , Albuminas/metabolismo , Sítios de Ligação , Cartilagem/metabolismo , Caseínas/metabolismo , Cumarínicos/metabolismo , Eletroforese , Imunodifusão , Cinética , Fosforilase a/metabolismo , Proteoglicanas/metabolismo , Soroalbumina Bovina/metabolismoRESUMO
The purpose of this investigation was to study the effect of fatty acid on carbohydrate metabolism in contracting vascular smooth muscle. The glycogen content of porcine carotid artery incubated in media containing only glucose decreased markedly upon contraction with 80 mM KCl. In contrast, when 0.5 mM palmitate was included there was no decrease in glycogen. Furthermore, the maximal isometric force generated was 22% greater than in the absence of palmitate (P less than 0.001). Stimulation of glycogen phosphorylase a activity with contraction was also enhanced with palmitate. Palmitate had no effect on the levels of the high energy phosphates under any substrate condition. Thus, fatty acid profoundly affects glycogen metabolism and contractility in vascular smooth muscle.
Assuntos
Glicogênio/metabolismo , Contração Muscular/efeitos dos fármacos , Músculo Liso Vascular/metabolismo , Ácidos Palmíticos/farmacologia , Animais , Artérias Carótidas , Cinética , Lactatos/metabolismo , Ácido Láctico , Músculo Liso Vascular/efeitos dos fármacos , Ácido Palmítico , Fosforilase a/metabolismo , Potássio/farmacologia , SuínosRESUMO
The activities of phosphorylase b kinase and phosphorylase a phosphatase were determined during the phases of KCl-induced contraction in porcine carotid artery. Phosphorylase b kinase exhibited a biphasic pattern with activity increasing 70% above basal levels during the early phase of active force generation (45 s into contraction) followed by a decline in activity during the phase of steady-state tension maintenance. Phosphorylase a phosphatase was stimulated simultaneously with phosphorylase b kinase, with activity increasing 100% over basal levels at 45 s into contraction, but remaining elevated at 30 min. Incubation of arteries in 0.5 mM palmitate resulted in a 30% increase in basal activity of phosphorylase b kinase and 117% augmentation of basal phosphatase activity, with no further increase in activity of either enzyme with contraction. The results indicate that both the kinase and phosphatase are subject to regulation during contractile activation of the muscle, possibly by similar but not identical mechanisms.
Assuntos
Músculo Liso Vascular/enzimologia , Ácidos Palmíticos/farmacologia , Fosforilase Quinase/metabolismo , Fosforilase Fosfatase/metabolismo , Animais , Artérias Carótidas/enzimologia , Artérias Carótidas/fisiologia , Ativação Enzimática/efeitos dos fármacos , Técnicas In Vitro , Contração Isométrica/fisiologia , Músculo Liso Vascular/fisiologia , Ácido Palmítico , Fosforilase a/metabolismo , Fosforilase b/metabolismo , SuínosRESUMO
The effects of adrenalectomy on cell calcium metabolism and on the effects of epinephrine on cAMP, phosphorylase a activity, and calcium efflux were studied in hepatocytes isolated from adult male and female rats. Adrenalectomy increased the total calcium of hepatocytes, all exchangeable calcium pools, and all calcium fluxes between the cellular pools in both sexes. After adrenalectomy, basal cAMP was elevated, phosphorylase a + b was decreased, but basal phosphorylase a activity was not changed. In adrenalectomized males and at all concentrations of epinephrine studied (1.10(-8)-1.10(-5)M) stimulation of calcium efflux was decreased and cAMP accumulation was enhanced, while the resulting phosphorylase a activation was depressed. In hepatocytes from adrenalectomized females there was a similar increase in cAMP accumulation induced by epinephrine, and a decrease in the stimulation of calcium efflux; however, the depression in phosphorylase a activation was much less and was significant only at 1.8(-8) and 1.10(-5)M epinephrine. In the male, while activation of phosphorylase a shifted from a pure alpha-adrenergic response mediated by calcium to one also involving a cAMP-mediated beta-adrenergic response, the contribution of the attenuated calcium signal was still significant. Hepatocytes from female rats did not show a comparable alpha- to beta-shift, since the relative contribution of calcium and cAMP to phosphorylase activation was similar in sham-operated and adrenalectomized animals.
Assuntos
Adrenalectomia , Cálcio/metabolismo , Epinefrina/farmacologia , Fígado/metabolismo , Animais , AMP Cíclico/metabolismo , Feminino , Fígado/efeitos dos fármacos , Masculino , Fenoxibenzamina/farmacologia , Fosforilase a/metabolismo , Fosforilase b/metabolismo , Propranolol/farmacologia , Ratos , Ratos Endogâmicos , Fatores SexuaisRESUMO
We have used liposomes with incorporated pig kidney Na+,K(+)-ATPase to study vanadate sensitive K(+)-K+ exchange and net K+ uptake under conditions of acetyl- and p-nitrophenyl phosphatase activities. The experiments were performed at 20 degrees C. Cytoplasmic phosphate contamination was minimized with a phosphate trapping system based on glycogen, phosphorylase a and glucose-6-phosphate dehydrogenase. In the absence of Mg2+ (no phosphatase activity) 5-10 mM p-nitrophenyl phosphate slightly stimulated K(+)-K+ exchange whereas 5-10 mM acetyl phosphate did not. In the presence of 3 mM MgCl2 (high rate of phosphatase activity) acetyl phosphate did not affect K(+)-K+ exchange whereas p-nitrophenyl phosphate induced a greater stimulation than in the absence of Mg2+; a further addition of 1 mM ADP resulted in a 35-65% inhibition of phosphatase activity with an increase in K(+)-K+ exchange, which sometimes reached the levels seen with 5 mM phosphate and 1 mM ADP. The net K+ uptake in the presence of 3 mM MgCl2 was not affected by acetyl phosphate or p-nitrophenyl phosphate, whereas it was inhibited by 5 mM phosphate (with and without 1 mM ADP). The results of this work suggest that the phosphatase reaction is not by itself associated to K+ translocation. The ADP-dependent stimulation of K(+)-K+ exchange in the presence of phosphatase activity could be explained by the overlapping of one or more step/s of the reversible phosphorylation from phosphate with the phosphatase cycle.